Abstract
Breast cancer is a commonly diagnosed malignancy and the second leading cause of cancer-related death among American women today. The literature suggests that African American Women (AAW) are more likely to die from the disease each year compared to their White counterparts. A biological basis for this disparity exists—early age of onset, more advanced stage of the disease, more aggressive histological changes, and worse survival. Even though mechanisms underlying these disparities are poorly understood, recent studies suggest that the poorer breast cancer outcome observed in AAW may, in part, result from underlying molecular factors. The present review was undertaken to investigate if AAW do, in fact, develop a more aggressive form of breast cancer compared to other racial groups based on molecular level differences and social determinants. This review also addresses health policy changes that may be implemented to aid in eliminating this disparity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Grunda JM et al (2012) Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American Women diagnosed with breast cancer. BMC Res Notes 5:248
Ambrosone CB et al (2014) Genome-wide methylation patterns provide insight into differences in breast tumor biology between American women of African and European ancestry. Oncotarget 5(1):237–248
Mair B et al (2016) Gain- and loss-of-function mutations in the breast cancer gene GATA3 result in differential drug sensitivity. PLoS Genet 12(9):e1006279
Reeder-Hayes KE, Anderson BO (2017) Breast cancer disparities at home and abroad: a review of the challenges and opportunities for system-level change. Clin Cancer Res 23(11):2655
Barrow MA et al (2019) A functional role for the cancer disparity-linked genes, CRYβB2 and CRYβB2P1, in the promotion of breast cancer. Breast Cancer Res 21(1):105
Gao Q et al (2014) Crybb2 deficiency impairs fertility in female mice. Biochem Biophys Res Commun 453(1):37–42
Kumar KD, Kumar GS, Santhiya ST (2012) Nonspecific PCR amplification of CRYBB2-pseudogene leads to misconception of natural variation as mutation. Invest Ophthalmol Vis Sci 53(9):5770–5770
Yao S, Ambrosone CB (2013) Associations between vitamin D deficiency and risk of aggressive breast cancer in African-American women. J Steroid Biochem Mol Biol 136:337–341
Gerend MA, Pai M (2008) Social determinants of black-white disparities in breast cancer mortality: a review. Cancer Epidemiol Biomark Prev 17(11):2913
Reeder-Hayes KE et al (2011) Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer. Breast Cancer Res Treat 128(3):863–871
Newman LA, Kaljee LM (2017) Health disparities and triple-negative breast cancer in African American women: a review. JAMA Surg 152(5):485–493
Danforth DN Jr (2013) Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors. Breast Cancer Res 15(3):208
Santa-Maria CA et al (2014) Aggressive estrogen-receptor-positive breast cancer arising in patients with elevated body mass index. Int J Clin Oncol. https://doi.org/10.1007/s10147-014-0712-4
Tammemagi CM et al (2005) Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 294(14):1765–1772
Oseni TO, Soballe PW (2014) Breast cancer screening patterns among military beneficiaries: racial variations in screening eliminated in an equal-access model. Ann Surg Oncol 21(10):3336–3341
Allicock M et al (2013) African American women's perspectives on breast cancer: implications for communicating risk of basal-like breast cancer. J Health Care Poor Underserved 24(2):753–767
Sturtz LA et al (2014) Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer. BMC Cancer 14:62
Chu QD et al (2012) Outcome for patients with triple-negative breast cancer is not dependent on race/ethnicity. Int J Breast Cancer 2012:764570
Williams P, Sallar A (2014) Knowledge, attitude, and prostate cancer-screening experience among African American men in southside Chicago: intervention strategy for risk reduction activities. J Racial Ethn Health Dispar 1(1):52–60
Reeder-Hayes KE et al (2014) Racial disparities in initiation of adjuvant endocrine therapy of early breast cancer. Breast Cancer Res Treat 145(3):743–751
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pellom, S.T., Arnold, T., Williams, M. et al. Examining breast cancer disparities in African Americans with suggestions for policy. Cancer Causes Control 31, 795–800 (2020). https://doi.org/10.1007/s10552-020-01322-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-020-01322-z